The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.

Twenty-seven of 152 patients (18%) with progressing hormone resistant prostate cancer had normal serum levels of prostate specific antigen (PSA less than or equal to 10 micrograms l-1), when referred for secondary treatment. PSA was significantly correlated with the extent of skeletal metastases (R:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosså, S. D., Waehre, H., Paus, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977889/
https://www.ncbi.nlm.nih.gov/pubmed/1379059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977889/
https://www.ncbi.nlm.nih.gov/pubmed/1379059

Ejemplares similares